In the News

1863 News Items found
Leiomyosarcoma expert Martee Hensley
In the Clinic
What’s New in Leiomyosarcoma?
In this Q&A, medical oncologist Martee Hensley discusses the diagnosis and treatment of leiomyosarcoma and other uterine sarcomas.
Metastatic tumor in the lung, with different colors used to represent the cell nuclei, the blood vessels, and the P-selectin protein.
In the Lab
A protein in blood vessels that plays a role in cancer metastasis is a promising target for delivering cancer drugs to tumors using nanoparticles.
A doctor speaks with a patient who has advanced prostate cancer about inherited mutations.
In the Clinic
Learn why a new finding suggests that men with advanced prostate cancer should be screened for gene mutations.
Man at airport
Feature
Traveling with cancer can be done, even if you’re in active treatment. Plan ahead so that you can fully enjoy your vacation.
Lymphoblastic leukemia survivor speaking at Fabulous and Fighting event for cancer patients.
Survivorship
Feelings of guilt are common after surviving cancer, but MSK offers many support services that can help patients feel better.
Memorial Sloan Kettering ovarian cancer patient Vilma Rosario and her partner, Michele Freeman, pose at the Statue of Liberty.
Feature
Meet a former NYPD officer who is battling a vicious enemy - ovarian cancer - with support from her new wife.
Palliative care nurse practitioner Tammy Son
In the Clinic
Learn how nurses at MSK also engage in cancer research projects designed to help improve patients’ treatment, symptoms, or experience.
MSK Pediatric Prom
Feature
Discover how current and former Memorial Sloan Kettering pediatric cancer patients closed out the end of the school year.
MSK gynecologic oncologist Carol Brown
Q&A
MSK physician Carol Brown spoke about cancer disparities at The US State of Women Summit organized by the White House. Learn how she and MSK are leading the way in addressing this issue.
MSK physician Aimee Crago consults with two colleagues.
In the Clinic
Learn more about olaratumab, a promising drug that has been shown to extend survival for people with advanced soft tissue sarcoma — particularly leiomyosarcoma — by nearly a year in a phase II clinical trial.